Cargando…

Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma

Patients with haematological malignancies are considered to be a risk group for developing severe Coronavirus disease (Covid-19). Because of the limitations of therapeutic options, the development of new treatment strategies is mandatory, such as convalescent plasma (CP). Herein we report the use of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ormazabal Vélez, Irati, Induráin Bermejo, Juan, Espinoza Pérez, José, Imaz Aguayo, Laura, Delgado Ruiz, Marina, García-Erce, José Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894088/ https://www.ncbi.nlm.nih.gov/pubmed/33637467 http://dx.doi.org/10.1016/j.transci.2021.103104

Ejemplares similares

Gammaglobulin: Lack of efficacy: case report
Publicado: (2022)

Gammaglobulin: Lack of drug effect for rhabdomyolysis: case report
Publicado: (2020)

Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy
por: Sánchez-Ramón, Silvia, et al.
Publicado: (2016)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Cefepime/convalescent-anti-sars-cov-2-plasma/rituximab: Relapsed COVID-19 and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Intravitreal rituximab for the treatment of a secondary intraocular relapse of a large B-cell lymphoma
por: Echegaray, Jose J., et al.
Publicado: (2018)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent-anti-sars-cov-2-plasma/rituximab/unspecified steroids: Fever and lymphodepletion: 2 case reports
Publicado: (2021)

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
por: Rahimi-Levene, Naomi, et al.
Publicado: (2022)

Convalescent plasma to treat COVID-19: clinical experience and efficacy
por: Pei, Shiyao, et al.
Publicado: (2021)

A look-back at convalescent plasma to treat COVID-19
por: Garraud, Olivier, et al.
Publicado: (2021)

Convalescent plasma to treat COVID-19: Following the Argentinian lead
por: Tiberghien, Pierre, et al.
Publicado: (2021)

Plasma exchange with COVID-19 convalescent plasma in a patient with severe ANCA-associated vasculitis and COVID-19 pneumonia after rituximab therapy
por: Kochanek, Matthias, et al.
Publicado: (2021)

Resistant and Relapsing Collapsing Glomerulopathy Successfully Treated with Rituximab—A Case Report
por: Zagorec, Nikola, et al.
Publicado: (2022)

International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
por: Murphy, Michael, et al.
Publicado: (2020)

Convalescent plasma to treat COVID-19: Its challenges in Iraq's situation
por: Hashim, H.T.
Publicado: (2020)

Convalescent Plasma – Is it Useful for Treating SARS Co-V2 infection?
por: Ranganathan, Sudha, et al.
Publicado: (2020)

Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab
por: Falter, Tanja, et al.
Publicado: (2018)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

The Predictive Role of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), Monocytes-to-Lymphocyte Ratio (MLR) and Gammaglobulins for the Development of Cutaneous Vasculitis Lesions in Primary Sjögren’s Syndrome
por: Mihai, Ancuta, et al.
Publicado: (2022)

Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19
por: De Santis, Gil Cunha, et al.
Publicado: (2021)

549. Clinical Characteristics and Outcomes of Patients with COVID-19 treated with Convalescent Plasma in Miami, Florida
por: Anjan, Shweta, et al.
Publicado: (2020)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
por: Delgado-Fernández, Marcial, et al.
Publicado: (2022)

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
por: Delgado-Fernández, Marcial, et al.
Publicado: (2022)

Relapsing granulomatosis with polyangiitis with severe lung and upper respiratory tract involvement successfully treated with rituximab
por: Masiak, Anna, et al.
Publicado: (2017)

Convalescent-anti-sars-cov-2-plasma/dexamethasone/rituximab: Depletion of B-lymphocytes, lack of efficacy and off label treatment: case report
Publicado: (2022)

Scarlatina Treated with Convalescent Serum
Publicado: (1914)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Convalescent plasma: Alternative or promising therapy?
por: Mina, Fahmida Begum, et al.
Publicado: (2021)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma
por: Einollahi, Behzad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g1bb805gdfsduofq5f51u5gbep